AZBio and its partners have programs strategically designed to help improve access to capital for our Arizona Life Science Industry and to preserve capital through AZBio Purchasing Power Programs.
How well they work depends on you.Continue reading
AZBio and its partners have programs strategically designed to help improve access to capital for our Arizona Life Science Industry and to preserve capital through AZBio Purchasing Power Programs.
How well they work depends on you.Continue reading
Company: Ulthera, Inc.
Position: Human Resources Generalist
Job Description:
Ulthera is continuing to grow and has an immediate need for a Generalist with experience in Recruiting.
We would strongly prefer someone who has worked in the healthcare segment and/or someone who has worked in an environment with very little direction/process (we are in late stage start-up so people have to be able to find their own answers and just “make it work”).
The pace at Ulthera is incredibly fast with project prioritization being a required skill based on too much to do and not enough time being a standard scenario. Our purpose-driven culture dictates the need for someone who is kind, ethical and very sharp.
This should be someone who people easily connect with and confide in while still being process oriented enough to get every spreadsheet and task completed meticulously.
It’s a tall order, it always is when you are looking for the best!
Contact Ulthera if you know of anyone who might be a fit and feel free to pay this forward and pass it on!
Who to contact: Stacie Mallen s.mallen@ulthera.com OR Leticia Gastelum l.gastelum@ulthera.com
Career site: careers.ultherapy.com/
Clinical Coordinator/Technical Writer
VisionGate Corporation
275 N. Gateway Dr. Phoenix, AZ 85034
VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™. VisionGate is expanding its team in Phoenix that will carry the development and commercialization of its products forward.
Position Summary
VisionGate is currently commercializing its LuCED test for early detection of lung cancer. We are also partnering with several institutions locally and internationally who will supply study specimens that will be used to evaluate the LuCED test. Development of other tests based on the Cell-CT are being considered or are in progress. To facilitate our development and clinical programs we seek to add a staff member who will coordinate these clinical studies. Responsibilities will also involve creation of clinical study protocols and reports, abstracts for publications, and other documentation required in a regulated environment. The position will report to the VisionGate CTO and may develop into a management role. Some travel may be required.
Roles and Responsibilities
Training and Experience
To apply contact Michael Meyer, meyer@visiongate3d.com
IT Support Engineer
VisionGate Corporation
275 N. Gateway Dr. Phoenix, AZ 85034
VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™. VisionGate is expanding to carry the development and commercialization of its products forward.
Position Summary
VisionGate is currently commercializing its LuCED test for early detection of lung cancer. Development of other tests based on the Cell-CT are being considered or are in progress. To facilitate commercialization of our tests and manage our research IT environment, we seek to add a part-time staff member who will help manage and grow our IT Infrastructure.
Roles and Responsibilities
Training and Experience
To apply contact Rahul Katdare, katdare@visiongate3d.com
Northern Arizona University
Position:
Senior Research Development and Commercialization Associate
Job Description:
The Senior Research Development and Commercialization Associate is charged with sourcing, building and maintaining strong, productive relationships with faculty, staff and student researchers and innovators-as well as with existing/prospective licensees, industry partners, entrepreneurs, and the local, regional and national innovation management community-for the purpose of catalyzing research and technology development and pushing university innovations from the lab to the marketplace. The Senior Research Development and Commercialization Associate participates in decision-making associated with institutional-level research investments and also manages an assigned portfolio of technologies from initial invention disclosure through the commercial life of the technologies. Reports to the Chief of Staff, Office of the Vice President for Research and Director of NAU Innovations (one individual).
VisionGate is dedicated to saving lives through early cancer detection and prevention. The Cell-CT™ is a revolutionary automated 3D cell imaging platform that generates high-resolution 3D biosignatures from intact cells. They are currently recruiting for a CLIA Lab Director.Continue reading
This competitive grant enables Arizona-based technology companies to initiate the commercialization process. Total funds available for this grant round are $175,000.
Maximum awards of $5,000 and $20,000 will enable companies to accomplish one of four scopes of work.
Innovation in Manufacturing Award $20,000
Proposer Match (50%) $10,000
Sub Total $30,000
Total of Manufacturing Partners’ Match (25%) $7,500
Total Grant Value $37,500
Important Details
We are very pleased to announce the opening of the submission window for the Spring 2014 Arizona Innovation Challenge (AIC) on March 3rd !! Continue reading
The National Institute of Standards & Technology (NIST) SBIR solicitation, originally scheduled for October 2013, was finally released February 19, 2014 with a closing date of May 2, 2014.Continue reading